Lexicon Pharmaceuticals Announces INPEFA Has Received Coverage From Express Scripts On Its Basic And High Performance Formularies For Commercially Insured Patients
Portfolio Pulse from Benzinga Newsdesk
Lexicon Pharmaceuticals announced that INPEFA has received coverage from Express Scripts on its basic and high performance formularies for commercially insured patients.
November 01, 2023 | 1:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Lexicon Pharmaceuticals' INPEFA has received coverage from Express Scripts, potentially increasing its accessibility and sales.
The coverage of INPEFA by Express Scripts on its formularies means that the drug will be more accessible to commercially insured patients. This could lead to an increase in sales for Lexicon Pharmaceuticals, potentially positively impacting its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100